The study was undertaken to determine whether polymorphic variants of the ␣-adducin gene are associated with isolated systolic hypertension (ISH) in elderly Australian Caucasians. Participants were classified with ISH (n ‫؍‬ 87, systolic blood pressure (SBP) у160 mm Hg and diastolic blood pressure (DBP) р90 mm Hg) or normotension (n ‫؍‬ 124, SBP Ͻ140 mm Hg and DBP Ͻ90 mm Hg with no family history of hypertension). To collect demographic data, a structured questionnaire was used. DNA was extracted using standard techniques from 211 subjects (age range 61-89, mean age 73 ؎ 6.6 years, male: female ratio 1.1:1). Genotypes (gly/gly, trp/gly and trp/trp) were assigned in triplicate by polymerase chain reaction (PCR) followed by electrophoresis, using a laser scanning electrophoresis unit. The validity of the method was confirmed by sequencing. Frequencies of allele distribution in ISH or control groups were determined by Chi-square tests and a stepwise logistic regression model, which controlled for potential confounders, was used to examine any independent association between ␣-adducin genotypes or
Introduction
Essential hypertension is a disorder associated with an increased risk of myocardial infarction, stroke, coronary artery disease and renal failure, for which both genetic and environmental factors may be responsible. 1 Approximately 20% to 40% of the blood pressure (BP) variability is attributable to genetic variation among individuals. 2 Adducin is a membrane cytoskeleton protein possibly modulating sodium ion transport, alteration of which has potent influence on BP regulation. 3 The 460Trp allele of the ␣-adducin gene has . In this elderly cohort, after adjustment for potential confounders, no statistically significant association was found between ␣-adducin genotype and SBP (P ‫؍‬ 0.65 for homozygotes, P ‫؍‬ 0.59, for heterozygotes), DBP (P ‫؍‬ 0.49 homozygotes, for heterozygotes P ‫؍‬ 0.45) pulse pressure (P ‫؍‬ 0.87 homozygotes, for heterozygotes P ‫؍‬ 0.95) diagnosis of ISH (P ‫؍‬ 0.72 for homozygotes, P ‫؍‬ 0.68 for heterozygotes). However age and renal disease predicted the diagnosis of ISH (P ‫؍‬ 0.001, P ‫؍‬ 0.459, respectively), a large pulse pressure (P Ͻ 0.0001, P ‫؍‬ 0.033, respectively) and a higher SBP (P Ͻ 0.0001, P ‫؍‬ 0.025, respectively) in this large cohort of elderly Australian Caucasian volunteers. Journal of Human Hypertension (2000) 14, 199-203. been reported to associate with hypertension, with a relative risk of 1.6 (approximately). 4 A study conducted in French families found a significant linkage between the ␣-adducin gene and the development of hypertension particularly salt-sensitive hypertension. 5 While the D4S95 genotype was significantly more common in hypertensive patients, it contributed only 5% to the overall BP variability in humans but 50% in milan hypertensive strain rats (MHS). These huge BP variability differences were partly attributed to heterogeneity of human disease. 6, 7 Although some studies 3, 5, [8] [9] [10] [11] have found a positive association between polymorphic variants of the ␣-adducin gene and hypertension, others 1, 12, 13 have failed to reveal any significant association. Importantly, no published studies have focused on isolated systolic hypertension (ISH) patients or the elderly. We evaluated the 460Trp mutant of the ␣-
Materials and methods
Subjects were recruited from an Australian-wide study investigating the prevalence of ISH, 14 the Princess Alexandra Hospital out-patients department and advertisements through local newspapers. All subjects provided informed consent. ISH was defined as systolic blood pressure (SBP) у160 mm Hg and diastolic blood pressure (DBP) Ͻ90 mm Hg and normotension as SBP Ͻ140 mm Hg and DBP Ͻ90 mm Hg with no family history of hypertension. Control subjects were recruited from the same population as ISH patients to minimise selection bias. On three separate clinical visits, BP was recorded using a mercury sphygmomanometer three times each visit at 2-min intervals following a 5-min rest in the sitting position. If patients were found to fulfil the criteria for ISH on the second visit, home BP recording was undertaken, after explanation, over the next 3 days. The diagnosis was based on the BP recordings at the three visits and home BP monitoring using the criteria above.
A structured questionnaire was used to collect demographic data (age, sex, height, weight, family history of hypertension, current BP, diabetes, heart disease and/or kidney disease, alcohol intake, cigarette smoking and physical exercise).
Five ml blood was collected by venesection from 211 ISH and normotensive elderly subjects for DNA extraction and a modified salting out method was used. 15 Polymerase chain reaction (PCR) was performed using a Hybaid PCR Express thermal cycler (model no: HBXc 220, UK) in a 15 l reaction volume containing 50 mM KCl, 10 mM Tris-HCl pH 8.3, 3 mM MgCl 2 , 0.3 units Red Hot Thermostable DNA Polymerase (Advanced Biotechnologies, UK), 200 M dNTPs (Promega, Madison, WI, USA) and 0.6 M adducin 1 primer (5Ј GGG GCG ACG AAG CTT CCG AGG TAG 3Ј), 0.3 M adducin 2 primer (5Ј GCT GAA CTC TGG CCC AGG CGA CGA AGC TTC CGA GGA TT 3Ј), 0.6 M 3 primer (5Ј CCT CCG AAG CCC CAG CTA CCC A 3Ј) (Life Technologies, Australia) and 90 ng DNA. Cycling conditions were: initial denaturation for 3 min at 95°C, followed by 35 cycles of denaturation for 20 sec at 94°C, annealing for 30 sec at 60°C and extension for 30 sec at 72°C. 1 PCR products were analysed on 4.5% polyacrylamide gels using a laser scanning electrophoresis unit (Corbett Research, Australia). ONE-Dscan v1.2 (Scanalytics, Billerica, MA, USA) was used to assign genotypes. All samples were assayed and analysed in triplicate.
Sequencing was performed on a representative of each genotype to confirm that the genotypes assigned by allele specific PCR were correct. Three DNA samples representing all possible genotypes (gly/gly, trp/gly and trp/trp) were amplified by PCR using 0.8 M adducin F2 primer (5Ј GAG TCA TAG GGT ATG CAT GTG 3Ј) and 0.8 M adducin R2 primer (5Ј CAG GTT TAG GAC TGA AGT GTC3Ј) (Life Technologies, Australia) and were purified using the QIAquick PCR Purification Kit (Qiagen, Australia) according to the suggested protocol. Sequencing reactions on purified PCR products were performed using the Thermo Sequenase dye terminator cycle sequencing Kit (Amersham Life Science Products, Australia) according to the suggested protocol and 0.3 M ADDUCINSEQ primer (primer 5Ј HexCAG TGG ACT TAG GTT CAG AC3Ј, Life Technologies, Australia). Sequencing reaction products were run on 4.5% polyacrylamide gels and analysed using DNA scan v2.1 (Scanalytics USA).
All data were stored on a PC in Microsoft Excel and reported as mean ± s.d. Pulse pressure was calculated as the differences between systolic and diastolic BP. Chi-square tests were used to examine unadjusted differences in genotype between groups.
Stepwise logistic regression modelling was used to evaluate any association between polymorphic variants of the ␣-adducin gene and ISH or normotensive controls after adjustment for potential confounders (age, sex, height, weight, current BP, diabetes, heart disease and/or kidney disease, alcohol intake, cigarette smoking and physical exercise). Interactions between all classified groups and other demographic variables (age, sex, height, weight, current BP, diabetes, heart disease and/or kidney disease, alcohol intake, cigarette smoking and physical exercise) were also assessed. All analyses were performed using the Statistix package (Analytical Software, USA).
Results
A total of 211 subjects (male:female ratio 1.1:1), mean age 73 ± 6.6 years and age range (61-89 years), body mass index (BMI 25 ± 4.1 kg/m 2 ), mean SBP 141.9 ± 26.4 mm Hg, mean DBP 76 ± 8.5 mm Hg and pulse pressure 66.1 ± 24.2, were included in this study. The subjects were classified as ISH (n = 87, mean BP 170/79.8 ± 14.9/8.3) and normotensive controls (n = 124, mean BP 122.1/73.4 ± 8.8/7.6). Patients with ISH had a mean age of 73.7 ± 6.4 years (male:female ratio 1:1.2) and a mean BMI of 25.6 ± 4.3. Normotensive control subjects had a mean age of 71.9 ± 6.6 years (male: female ratio 1:0.7) and a mean BMI of 24.6 ± 3.9 (Table 1) .
Sequencing confirmed that the genotypes assigned by allele-specific PCR were correct. Hardy-Weinberg equilibrium was maintained in the normotensive controls ( 2 = 0.3). For all participants combined there was no significant difference in unadjusted ␣-adducin genotype and allele frequencies amongst ISH and normotensive controls groups ( 2 = 1.59, P = 0.5; 2 = 1.23, P = 0.3 respectively) ( Table 2) . In a stepwise regression model after statistical adjustment for age, sex, BMI, current smoker status, alcohol intake, prevalence of heart disease, renal disease and diabetes, there was no significant association between ␣-adducin genotype and having ISH (P = 0.72 for homozygotes, P = 0.68 for heterozygotes) (Table 3) . However, age (P = 0.001) and renal disease (P = 0.459) were significant predictors of the presence of ISH. There was no significant association demonstrated between the remaining variables and the presence of ISH.
Similarly, SBP, DBP and pulse pressure in the total cohort were not predicted by ␣-adducin genotype (P = 0.65, P = 0.49, P = 0.87 for homozygotes
Journal of Human Hypertension and P = 0.59, P = 0.45, P = 0.95 for heterozygotes, respectively) ( Table 3 ). In the total cohort, however SBP was predicted by BMI (P = 0.048), age (P Ͻ 0.0001) and renal disease (P = 0.025), DBP was predicted by BMI (P = 0.0366) and pulse pressure was predicted by age (P Ͻ 0.0001) and renal disease (0.033).
Discussion
In these elderly patients and controls of Caucasian descent, no significant association was found between ␣-adducin genotype and SBP, DBP and pulse pressure, in the prediction of ISH. No significant interactions were detected between genotype and all the demographic variables studied.
Aging and prevalence of renal disease may be important predictors of patients having ISH. Age was also significantly predictive of all hypertension in these elderly volunteers. Importantly, aging was significantly associated with SBP and pulse pressure but not with DBP. BMI was independent predictors of SBP and DBP. Previous studies also reported that there was a positive association between having ISH and increasing age. [16] [17] [18] [19] In 603 Scottish families the 460Trp variant of the ␣-adducin gene failed to demonstrate any significant change in either BP or sodium metabolism. 13 In 507 Japanese individuals, the 460Trp variant of the ␣-adducin was more prevalent (54% to 60%) than in Caucasians (13% to 23%) but did not find any significant association with essential hypertension in this Japanese population. However, there was a borderline association (P = 0.05) found between SBP and the 460Gly variant of the ␣-adducin gene. The study suggested that ethnicity may be a predisposing factor in the nature of genetic susceptibility loci in the pathogenesis of essential hypertension. 1 From 211 subjects, 209 were included in the final analysis. Two subjects were excluded because it was not possible to extract adequate quantities of satisfactory DNA from those samples. Potential selection bias was partly minimised by not including from the normotensive controls subjects with a positive past and/or family history of hypertension and by choosing volunteers from all Australian states across a wide geographical distribution. However, selection bias is possible because some ISH patients included in the study were already on BP medication and because ambulatory BP monitoring (which can reduce false-positive response, white-coat influence and observer bias) [20] [21] [22] [23] [24] [25] [26] was not used for diagnosis. We calculated the power 27 of this study and although the power to find a P value Ͻ0.05 was less than 50% there were other important factors which must be taken into consideration. This study included samples which were drawn from an Australian-wide cross-section of a well-defined epidemiological study. 14 Multiple other studies (conducted in 507 Japanese individuals 1 and in 603 Scottish families 13 ) with larger sample sizes also failed to demonstrate any significant association between the ␣-adducin gene and hypertension.
No significant association was found between the ␣-adducin genotype and ISH patients in the elderly Australian Caucasians studied. Possibly, a much bigger sample would be required to undertake linkage study which may better explore whether or not the molecular variants of the ␣-adducin gene are responsible for hypertension in elderly Australian population. Comparative studies of the possible association of the ␣-adducin gene in various ethnic groups and investigations of different polymorphisms within the ␣-adducin gene could be explored to determine any association between the ␣-adducin gene and elderly Australian population. In Japanese and other ethnic populations, further studies, including the generation of haplotypes and family-based tests for linkage disequilibrium, would be required to reveal whether or not the molecular variants of the ␣-adducin gene are responsible for hypertension. [28] [29] [30] The variation among frequences of ␣-adducin genetic variants, the presence of hypertension and ethnicity in various studies has been demonstrated not only for the ␣-adducin gene but for the angiotensinogen and S A genes (also associated with hypertension). 31 Therefore, it is very important to recognise the local relevance for hypertension of the specific genetic markers within different ethnic groups. 13 It is also possible that in some individuals genetic predisposition of hypertension may not be revealed unless there has been exposure to a suitable environment including for example a high Na and low K diet.
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Conclusion
There was no significant association found between polymorphism of the ␣-adducin gene and ISH patients in elderly Caucasian Australian volunteers. However, age and renal disease are significantly associated with the presence of ISH. In addition they predict a large pulse pressure and a higher SBP. Ethnicity may influence the impact of genetic factors on the pathogenesis of hypertension.
